510(k) Report

510(k) · Cleared

Cleared

Angioguard XP Emboli Capture Guidewire, Angioguard RX Emboli Capture Guidewire

K101651510(k) SpecialCleared Jul 9, 201028-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Corp. · NTE Temporary Carotid Catheter For Embolic Capture

Cleared on Jul 9, 2010 as substantially equivalent to K062531 (Cordis Corp., A Johnson & Johnson Co., 2006) after a 28-day review. Its family tree reaches back 1 generation to 2006. 2 of the 7 devices in its family, counting itself, have a Class I recall. 5 later devices descend from it.

Decided
Jul 9, 2010
Review
28 days
Class
Class II
Product code
NTE
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K062531 (2006). 5 later devices descend from it, 2 citing it directly. 2 of the 7 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2022: 1 descendant cleared, 1 with a Class I recall12015: 1 descendant cleared2018: 1 descendant cleared2020: 1 descendant cleared2021: 1 descendant cleared, 1 with a Class I recall1K062531 · Angioguard XP Emboli Capture Guidewire and Angioguard RX Emboli Capture Guidewire · Cordis Corp., A Johnson & Johnson Co. · 200620052010201520202025
Descendants, by generation 1 generation forward: 2 descendants, 1 with a Class I recall12 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant, 1 with a Class I recall1 K062531 · Angioguard XP Emboli Capture Guidewire and Angioguard RX Emboli Capture Guidewire · Cordis Corp., A Johnson & Johnson Co. · 20060
  1. Root · 1 generation backK062531 Angioguard XP Emboli Capture Guidewire and Angioguard RX Emboli…Cordis Corp., A Johnson & Johnson Co. · 2006
  2. This deviceK101651 Angioguard XP Emboli Capture Guidewire, Angioguard RX Emboli Capture…Cordis Corp. · 2010
  3. Descendant · cites it directly · 3 of its ownK143570 WirionGardia Medical · 2015
  4. Descendant · 2 generations on · 2 of its ownK180023 WirionGardia Medical, Ltd. · 2018
  5. Descendant · 3 generations on · 1 of its ownK200198 WirionCardiovascular Systems, Inc. · 2020
  6. Descendant · cites it directly · 0 of its ownK220654 ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture…Cordis Corporation · 2022 · Recalled (Class I)
  7. Descendant · 4 generations on · 0 of its ownK210282 WIRION Embolic Protection SystemCardiovascular Systems, Inc. · 2021 · Recalled (Class I)

Class I recalls in this family

Most influential descendants

Showing 5 of 5 · See all
  • K143570WirionGardia Medical · 2015 · cites it directly3descendants
  • K180023WirionGardia Medical, Ltd. · 2018 · 2 generations on2descendants
  • K200198WirionCardiovascular Systems, Inc. · 2020 · 3 generations on1descendant
  • K220654ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture GuidewireCordis Corporation · 2022 · cites it directly0descendants
  • K210282WIRION Embolic Protection SystemCardiovascular Systems, Inc. · 2021 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K062531Angioguard XP Emboli Capture Guidewire and Angioguard RX Emboli Capture…Cordis Corp., A Johnson & Johnson Co.2006—
0 (this device)K101651Angioguard XP Emboli Capture Guidewire, Angioguard RX Emboli Capture GuidewireCordis Corp.2010—
+1K143570WirionGardia Medical2015—
+2K180023WirionGardia Medical, Ltd.2018—
+3K200198WirionCardiovascular Systems, Inc.2020—
+1K220654ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture GuidewireCordis Corporation2022Class I
+4K210282WIRION Embolic Protection SystemCardiovascular Systems, Inc.2021Class I

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
201810
202010
202111
202211
FIG. 1 — Lineage of K101651, 2006–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NTE device

  1. #1 K222694 EmPro EPS (EP4514C-190…score 6.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062531Angioguard XP Emboli Capture Guidewire and Angioguard RX Emboli Capture Guidewire
Our reading of the summary gave “K062531” beside “510(k)”; FDA’s K062531 is the only number that fits it and was decided on the date printed beside it.
Summary page 1
…n System (K023691) and PercuSurge, Inc.'s Percusurge Guardwire Temporary Occlusion and Aspiration System (K013913) via 510(k) K062531 on September 22, 2006.…
Cordis Corp., A Johnson & Johnson Co.2006—
*—ANGIOGUARD RX Emboli Capture Guidewire
Named without a submission number
—

Also cleared against K062531: 1 other device →

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K143570WirionGardia Medical20153
K220654ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture Guidewire Class ICordis Corporation20220

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K220654ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture GuidewireCordis Corporation · 2022 · Cites it directly · ◆ in the 2022 descendants bar of FIG. 114 Class I recalls
  • K210282WIRION Embolic Protection SystemCardiovascular Systems, Inc. · 2021 · 4 generations on · ◆ in the 2021 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K143570 (Gardia Medical, 2015) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K062531.

How does its category compare?

All NTE devices

NTE Temporary Carotid Catheter For Embolic Capture: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · NTE

2in 2023

2007: 12008: 32009: 32010: 12011: 42012: 32014: 12015: 32016: 12018: 12019: 12020: 12021: 12022: 12023: 2
2007high 4 (2011) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NTE

105in 2015

2008: 95 days median2009: 86 days median2011: 105 days median2012: 30 days median2015: 105 days median
2007high 105 (2011) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NTE

3in 2023

2008: 62011: 12021: 1, 1 Class I2023: 32026 (partial year): 2, 2 Class I
2007high 6 (2008) · low 0 (2007)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · NTE

405in 2025

2007: 1192008: 3682009: 3432010: 2942011: 3042012: 2612013: 2582014: 1992015: 1482016: 1482017: 1412018: 1582019: 2332020: 2382021: 3272022: 3262023: 3542024: 3982025: 405
2007high 405 (2025) · low 119 (2007)2025

MAUDE reports naming product code NTE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0119
20083956368
20093860343
20101—0294
201141051304
20123300261
20130—0258
20141—0199
201531050148
20161—0148
20170—0141
20181—0158
20191—0233
20201—0238
20211—1 (1)327
20221—0326
20232—3354
20240—0398
20250—0405
20260—2 (2)—

What is it indicated for?

The ANGIOGUARD TMXP Emboli Capture Guidewire is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing carotid artery angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be from 3mm to 7.5 mm. The ANGIOGUARD TM RX Emboli Capture Guidewire is indicated for use as a guidewire and embolic protection…

Read the full statement (109 words)

The ANGIOGUARD TMXP Emboli Capture Guidewire is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing carotid artery angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be from 3mm to 7.5 mm.

The ANGIOGUARD TM RX Emboli Capture Guidewire is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing carotid artery angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be from 3mm to 7.5 mm.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101651: Angioguard XP Emboli Capture Guidewire, Angioguard RX Emboli Capture Guidewire.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K101651

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026